NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a liver-protecting herb boost leukemia chemo? new trial aims to find out.
Disease control Recruiting nowThis study is for adults newly diagnosed with a type of acute myeloid leukemia (non-M3). It tests whether adding silibinin, a natural compound from milk thistle that protects the liver, to standard chemotherapy can improve remission rates and survival. About 100 participants will…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE4 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for leukemia patients too frail for chemo: triple-drug combo shows promise
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) in people newly diagnosed with a specific type of leukemia (acute monocytic leukemia) who are not healthy enough for intensive chemotherapy. The goal is to see if this drug mix can put the canc…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for older AML patients: study tests smarter drug combos to beat relapse
Disease control Recruiting nowThis study compares four different drug combinations for adults newly diagnosed with acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy or choose not to have it. The goal is to see which combination works best to keep the cancer away longe…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Blood cancer study seeks to uncover transplant barriers
Knowledge-focused Recruiting nowThis study tracks over 1,300 people with blood cancers like acute leukemia to see how many receive a stem cell transplant. Researchers want to understand the medical and personal reasons why some patients get this treatment while others do not. The goal is to identify barriers so…
Matched conditions: NEWLY DIAGNOSED
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC